Authors:
WURL P
MEYE A
BERGER D
LAUTENSCHLAGER C
BACHE M
HOLZHAUSEN HJ
SCHMIDT H
DRALLE H
RATH FW
TAUBERT H
Citation: P. Wurl et al., SIGNIFICANCE OF RETINOBLASTOMA AND MDM2 GENE-EXPRESSION AS PROGNOSTICMARKERS FOR SOFT-TISSUE SARCOMA, LANGENBECKS ARCHIVES OF SURGERY, 383(1), 1998, pp. 99-103
Authors:
GOHRING B
HOLZHAUSEN HJ
MEYE A
HEYNEMANN H
REBMANN U
LANGNER J
RIEMANN D
Citation: B. Gohring et al., ENDOPEPTIDASE-24.11 CD10 IS DOWN-REGULATED IN RENAL-CELL CANCER, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2(4), 1998, pp. 409-414
Authors:
MEYE A
BACHE M
HINZE R
SCHMIDT H
WURL P
HOLZHAUSEN HJ
RATH FW
TAUBERT H
Citation: A. Meye et al., MOLECULAR CHARACTERIZATION AND LIPOSOMAL TRANSFECTION OF A P53-MUTATED CELL-LINE ESTABLISHED FROM A POORLY DIFFERENTIATED LEIOMYOSARCOMA, International journal of oncology, 13(2), 1998, pp. 241-248
Authors:
WURL P
MEYE A
SCHMIDT H
LAUTENSCHLAGER C
KALTHOFF H
RATH FW
TAUBERT H
Citation: P. Wurl et al., HIGH PROGNOSTIC-SIGNIFICANCE OF MDM2 P53 CO-OVEREXPRESSION IN SOFT-TISSUE SARCOMAS OF THE EXTREMITIES/, Oncogene, 16(9), 1998, pp. 1183-1185
Authors:
TAUBERT H
BERGER D
HINZE R
MEYE A
WURL P
HOGENDOORN PCW
HOLZHAUSEN HJ
SCHMIDT H
RATH FW
Citation: H. Taubert et al., HOW IS THE MUTATIONAL STATUS FOR TUMOR SUPPRESSORS P53 AND P16(INK4A)IN MFH OF THE BONE, Cancer letters, 123(2), 1998, pp. 147-151
Authors:
TAUBERT H
WURL P
BACHE M
MEYE A
BERGER D
HOLZHAUSEN HJ
HINZE R
SCHMIDT H
RATH FW
Citation: H. Taubert et al., THE P53 GENE IN SOFT-TISSUE SARCOMAS - PROGNOSTIC VALUE OF DNA-SEQUENCING VERSUS IMMUNOHISTOCHEMISTRY, Anticancer research, 18(1A), 1998, pp. 183-187
Authors:
SCHMIDT H
KORBER S
HINZE R
TAUBERT H
MEYE A
WURL P
HOLZHAUSEN HJ
DRALLE H
RATH FW
Citation: H. Schmidt et al., CYTOGENETIC CHARACTERIZATION OF 10 MALIGNANT FIBROUS HISTIOCYTOMAS, Cancer genetics and cytogenetics, 100(2), 1998, pp. 134-142
Authors:
WURL P
TAUBERT H
MEYE A
BERGER D
LAUTENSCHLAGER C
SCHMIDT H
HINZE R
RATH FW
SCHONFELDER M
Citation: P. Wurl et al., EXPRESSION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTOR FLK-1 IN SOFT-TISSUE SARCOMAS - CORRELATION TO CATHEPSIN EXPRESSION AND PROGNOSIS, Acta histochemica et cytochemica, 31(1), 1998, pp. 55-63
Authors:
MEYE A
WURL P
HINZE R
BERGER D
BACHE M
SCHMIDT H
RATH FW
TAUBERT H
Citation: A. Meye et al., NO P16(INK4A) CDKN2/MTS1 MUTATIONS INDEPENDENT OF P53 STATUS IN SOFT-TISSUE SARCOMAS/, Journal of pathology, 184(1), 1998, pp. 14-17
Authors:
WURL P
MEYE A
BERGER D
BACHE M
LAUTENSCHLAGER C
SCHMIDT H
KALTHOFF H
RATH FW
TAUBERT H
Citation: P. Wurl et al., PROGNOSTIC RELEVANCE OF C-TERMINAL MDM2 DETECTION IS ENHANCED BY P53 POSITIVITY IN SOFT-TISSUE SARCOMAS, Diagnostic molecular pathology, 6(5), 1997, pp. 249-254
Authors:
BACHE M
DUNST J
WURL P
FRODE D
DIETZEL M
MEYE A
SCHMIDT H
RATH FW
WOHLRAB W
DRALLE H
TAUBERT H
Citation: M. Bache et al., RADIATION-INDUCED G2 M BLOCK AND APOPTOSIS IN 2 HUMAN SARCOMA CELL-LINES WITH DIFFERENT P53 GENE STATUS/, International journal of oncology, 11(5), 1997, pp. 993-997
Authors:
TAUBERT H
SCHMIDT H
WURL P
HINZE R
MEYE A
BACHE M
BERGER D
HOLZHAUSEN HJ
DRALLE H
RATH FW
Citation: H. Taubert et al., MORPHOLOGICAL AND MOLECULAR CHARACTERIZATION OF AN UNDIFFERENTIATED SOFT-TISSUE SARCOMA CELL-LINE AND DERIVATIVE CLONES, International journal of oncology, 11(3), 1997, pp. 521-526
Authors:
WURL P
TAUBERT H
MEYE A
DANSRANJAVIN T
WEBER E
GUNTHER D
BERGER D
SCHMIDT H
DRALLE H
RATH FW
Citation: P. Wurl et al., IMMUNOHISTOCHEMICAL AND CLINICAL-EVALUATION OF CATHEPSIN EXPRESSION IN SOFT-TISSUE SARCOMAS, Virchows Archiv, 430(3), 1997, pp. 221-225
Authors:
BERGER D
PAUER HD
HINZE R
TAUBERT H
MEYE A
HOLZHAUSEN HJ
SCHMIDT H
RATH FW
HOGENDOORN PCW
Citation: D. Berger et al., MUTATION AND IMMUNOHISTOCHEMICAL INVESTIGATION OF TUMOR-SUPPRESSOR GENES P53 AND P16 IN MALIGNANT FIBROUS HISTIOCYTOMAS (MFH) OF THE BONE, European journal of cell biology, 72, 1997, pp. 260-260
Citation: A. Meye et al., OPTIMIZATION OF PLASMID TRANSFECTION PROTOCOLS (BALLISTO-MAGNETIC TRANSFER, CATIONIC LIPOSOMES) FOR HUMAN PRIMARY SOFT-TISSUE SARCOMA CELL-CULTURES, European journal of cell biology, 72, 1997, pp. 323-323
Authors:
TAUBERT H
MEYE A
BACHE M
KROLL J
HOLZHAUSEN HJ
HINZE R
SCHMIDT H
RATH FW
Citation: H. Taubert et al., P53 MUTATIONS AS PROGNOSTIC FACTOR FOR SOFT-TISSUE SARCOMA PATIENTS, European journal of cell biology, 72, 1997, pp. 331-331
Authors:
WURL P
DRALLE H
TAUBERT H
MEYE A
BERGER D
SCHMIDT H
HOLZHAUSEN HJ
RATH FW
Citation: P. Wurl et al., PROGNOSTIC-SIGNIFICANCE OF P53 IMMUNOHISTOCHEMISTRY FOR P53 MUTATED TUMORS, European journal of cell biology, 72, 1997, pp. 333-333
Authors:
WURL P
TAUBERT H
MEYE A
BERGER D
LAUTENSCHLAGER C
HOLZHAUSEN HJ
SCHMIDT H
KALTHOFF H
RATH FW
DRALLE H
Citation: P. Wurl et al., PROGNOSTIC VALUE OF IMMUNOHISTOCHEMISTRY FOR P53 IN PRIMARY SOFT-TISSUE SARCOMAS - A MULTIVARIATE-ANALYSIS OF 5 ANTIBODIES, Journal of cancer research and clinical oncology, 123(9), 1997, pp. 502-508
Authors:
WURL P
WEIGMANN F
MEYE A
FITTKAU M
ROSE U
BERGER D
RATH FW
DRALLE H
TAUBERT H
Citation: P. Wurl et al., DETECTION OF P53 AUTOANTIBODIES IN SERA OF GASTRIC-CANCER PATIENTS AND THEIR PROGNOSTIC RELEVANCE, Scandinavian journal of gastroenterology, 32(11), 1997, pp. 1147-1151
Authors:
WURL P
TAUBERT H
MEYE A
EICHFELD U
DRALLE H
Citation: P. Wurl et al., PROGNOSTICAL AND THERAPEUTIC RELEVANCE OF P53-MUTATIONS IN SOFT-TISSUE SARCOMAS, Langenbecks Archiv fur Chirurgie, 1996, pp. 527-531
Authors:
WURL P
TAUBERT H
BACHE M
KROLL J
MEYE A
BERGER D
SIERMANN A
HOLZHAUSEN HJ
HINZE R
SCHMIDT H
RATH FW
Citation: P. Wurl et al., FREQUENT OCCURRENCE OF P53 MUTATIONS IN RHABDOMYOSARCOMA AND LEIOMYOSARCOMA, BUT NOT IN FIBROSARCOMA AND MALIGNANT NEURAL TUMORS, International journal of cancer, 69(4), 1996, pp. 317-323
Citation: H. Taubert et al., PROGNOSIS IS CORRELATED WITH P53 MUTATION TYPE FOR SOFT-TISSUE SARCOMA PATIENTS, Cancer research, 56(18), 1996, pp. 4134-4136
Authors:
TAUBERT H
WURL P
MEYE A
BERGER D
THAMM B
NEUMANN K
HINZE R
SCHMIDT H
RATH FW
Citation: H. Taubert et al., MOLECULAR AND IMMUNOHISTOCHEMICAL P53 STATUS IN LIPOSARCOMA AND MALIGNANT FIBROUS HISTIOCYTOMA - IDENTIFICATION OF 7 NEW MUTATIONS FOR SOFT-TISSUE SARCOMAS, Cancer, 76(7), 1995, pp. 1187-1196